A Manhattan federal judge has ruled that an activist investor can be sued for allegedly making false statements in a heated proxy fight that got two of its nominees elected to a firm’s board of directors.

The decision, attorneys for plaintiff Enzo Biochem Inc. said, would give public companies a path to sue investors who make material misrepresentations in proxy statements while aggressively seeking to bring about corporate governance changes.